![]() LogicBio Therapeutics LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment. | ||
Founding Date | Founding Date 2018 | Founding Date 2014 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Lexington, US HQ Louisville, US |
Employees | Employees 188 | Employees 4178% increase |
Valuation ($) | Valuation ($) 243.3 m | Valuation ($) 176.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) $36k (FY, 2025) | Revenue (est.) $5.4m (FY, 2021) |
Net income | Net income ($274.4m) (FY, 2025) | Net income ($40m) (FY, 2021) |

LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment.
View company